Abstract
The EU Clinical Trial Register (EUCTR) is a public facing portal containing information on trials of medicinal products conducted in the European Union (EU) and European Economic Area (EEA). Today, the registry holds information on over 30,000 trials. Given its distinct regulatory purpose, and results reporting requirements, the EUCTR should be a valuable open-source hub for trial information. Past work examining the EUCTR has suggested that data quality on the registry may be lacking. Using the full EUCTR public dataset, we examined areas in which national regulators are expected to ensure data quality including the posting of registrations, updating trial completion information, and monitoring results posting in line with EU guidelines. We identified issues across all areas examined with notable research hubs like France, Spain, and The Netherlands lacking consistent and complete data on the registry. These deficiencies complicate the utility of the EUCTR for research, transparency, and accountability efforts.
Competing Interest Statement
The authors report no conflicts related to the submitted work. Outside of the submitted work NJD reports being employed on grants from the Laura and John Arnold Foundation (original TrialsTracker funder) and the Good Thinking Society (TrialsTracker funder) within the past 3 years; a grant from Fetzer Franklin Fund. BG reports receiving grants from the Laura and John Arnold Foundation (Original TrialsTracker funder), Good Thinking Society (TrialsTracker funder), Wellcome Trust, National Institute for Health Research (NIHR), NIHR School of Primary Care Research, Oxford Biomedical Research Centre, Mohn-Westlake Foundation, Health Foundation, and the World Health Organization outside the submitted work; receiving personal income from speaking and writing for lay audiences on the misuse of science; and being a cofounder of the AllTrials Campaign.
Funding Statement
Funding/Support: The TrialsTracker project was established with a grant from the Laura and John Arnold Foundation and received additional support from the Good Thinking Society. NJD's doctoral work is funded by the Naji Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This analysis used publicly available data on clinical trials, with no use of human subjects or individual patient data therefore it was exempt from ethics consideration at the University of Oxford
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data analysis was performed in Python 3.8.1 and all data and code can be accessed on GitHub at: https://github.com/ebmdatalab/euctr_data_quality. EUCTR scrapers can be accessed at: https://github.com/ebmdatalab/euctr-tracker-code and https://github.com/ebmdatalab/registry_scrapers_parsers
